Pee Safe Achieves Significant Exit with Venture Catalysts Support

Pee Safe, a prominent brand in women’s hygiene and wellness, has marked a significant milestone with a successful funding round of $32 million, led by global healthcare investment firm OrbiMed. This funding allowed early investors, including Venture Catalysts, to achieve liquidity through a secondary component, effectively turning long-term value into immediate cash returns.

Venture Catalysts’ Involvement with Pee Safe

Venture Catalysts first invested in Pee Safe in August 2017, backing the company at a crucial time when it transitioned from focusing on toilet hygiene to developing a comprehensive personal hygiene and wellness portfolio. This was following a pre-Series funding round raised in June 2017 that also included Venture Catalysts.

Successful Exit Strategy

The exit was finalised in January 2026, resulting in a remarkable 9.6x return on invested capital, along with an XIRR of 30.53% for the fund and its limited partners. Pee Safe achieved this success by employing an omnichannel strategy, making its products accessible through over 50,000 offline retail locations in more than 100 cities, as well as through e-commerce platforms and direct-to-consumer channels.

Consistent Growth and Future Plans

The brand has maintained robust growth, experiencing a year-on-year increase of approximately 45-50% over the past two years. According to Venture Catalysts, their commitment to partnering with entrepreneurs across healthcare, consumer, and technology sectors remains strong, as they seek scalable businesses with robust fundamentals and clear routes to liquidity.

Focus on High-Potential Startups

Venture Catalysts continues to prioritize identifying promising startups in their early stages, where their strategic capital and ongoing support can significantly enhance long-term value creation.